Changes in the former two proteins might imply a pro-angiogenic phenotype upon JBS2 and lapatinib co-treatment; indeed, there is evidence of VEGFA expression being associated with aggressive DCIS lesions [49], while high CAIX expression has been linked with a hypoxia-adaptive response in male DCIS [50]. This evidence concerns the gene VEGFA and ductal breast carcinoma in situ.